Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.99-0.53 (-8.13%)
At close: 04:00PM EDT
5.88 -0.11 (-1.84%)
After hours: 04:06PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/28/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
1.61B1.24B1.86B3.54B3.94B
Enterprise Value
1.06B692.23M1.31B2.78B4.41B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
183.2764.45183.03417.57363.70
Price/Book (mrq)
1.831.331.903.47N/A
Enterprise Value/Revenue
121.411.25k463.511.01k1.68k
Enterprise Value/EBITDA
-5.01-10.75-30.44-61.68-73.83

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-61.38%
S&P500 52-Week Change 3-11.93%
52 Week High 319.84
52 Week Low 33.57
50-Day Moving Average 35.06
200-Day Moving Average 37.74

Share Statistics

Avg Vol (3 month) 3904.74k
Avg Vol (10 day) 31.62M
Shares Outstanding 5246.14M
Implied Shares Outstanding 6N/A
Float 8131.31M
% Held by Insiders 115.88%
% Held by Institutions 159.12%
Shares Short (Jun 14, 2022) 416.31M
Short Ratio (Jun 14, 2022) 417.68
Short % of Float (Jun 14, 2022) 49.56%
Short % of Shares Outstanding (Jun 14, 2022) 46.63%
Shares Short (prior month May 12, 2022) 415.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,584.93%

Management Effectiveness

Return on Assets (ttm)-14.52%
Return on Equity (ttm)-33.80%

Income Statement

Revenue (ttm)8.76M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-77.40%
Gross Profit (ttm)10.65M
EBITDA -210.54M
Net Income Avi to Common (ttm)-263.32M
Diluted EPS (ttm)-1.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)613.91M
Total Cash Per Share (mrq)2.49
Total Debt (mrq)68.81M
Total Debt/Equity (mrq)7.81
Current Ratio (mrq)15.24
Book Value Per Share (mrq)3.59

Cash Flow Statement

Operating Cash Flow (ttm)-140.5M
Levered Free Cash Flow (ttm)-131.68M
Advertisement
Advertisement